We initially screened our cohort for the molecular ALL subtypes outlined by the International Consensus Classification (ICC)2 using a combination of genome-wide CNA detection, fusion gene screening (Supplementary Fig. 1), and targeted mutational assessment for PAX5 p.Pro80Arg, IKZF1 p.Asn159Tyr, and ZEB2 p.His1038Arg (Supplementary Data 2). This evidence concerns the gene ZEB2 and acute lymphoblastic leukemia.